In Search of the Most Suitable Lentiviral shRNA SystemJAN BOS, Tomas; DE BRUYNE, Elke; HEIRMAN, Carlo et al.Current gene therapy. 2009, Vol 9, Num 3, pp 192-211, issn 1566-5232, 20 p.Article

Vorinostat-induced bone loss might be related to drug toxicitySONG XU; DE VEIRMAN, Kim; VANDERKERKEN, Karin et al.Bone (New York, NY). 2013, Vol 57, Num 2, pp 384-385, issn 8756-3282, 2 p.Article

Large double copy vectors are functional but show a size-dependent decline in transduction efficiencyBOS, Tomas J; DE BRUYNE, Elke; VAN LINT, Sandra et al.Journal of biotechnology. 2010, Vol 150, Num 1, pp 37-40, issn 0168-1656, 4 p.Article

A unique pathway in the homing of murine multiple myeloma cells : CD44v10 mediates binding to bone marrow endotheliumASOSINGH, Kewal; GÜNTHERT, Ursula; DE RAEVE, Hendrik et al.Cancer research (Baltimore). 2001, Vol 61, Num 7, pp 2862-2865, issn 0008-5472Article

An Improved Harvest and in Vitro Expansion Protocol for Murine Bone Marrow-Derived Mesenchymal Stem CellsSONG XU; DE BECKER, Ann; VAN CAMP, Ben et al.Journal of Biomedicine and Biotechnology (Print). 2010, Vol 2010, issn 1110-7243, 105940.1-105940.10, 4Article

Multiple myeloma biology: lessons from the 5TMM modelsVANDERKERKEN, Karin; ASOSINGH, Kewal; CROUCHER, Peter et al.Immunological reviews. 2003, Vol 194, pp 196-206, issn 0105-2896, 11 p.Article

Multiple myeloma tumor progression in the 5T2MM murine model is a multistage and dynamic process of differentiation, proliferation, invasion, and apoptosisASOSINGH, Kewal; DE RAEVE, Hendrik; VAN RIET, Ivan et al.Blood. 2003, Vol 101, Num 8, pp 3136-3141, issn 0006-4971, 6 p.Article

The role of the insulin-like growth factor 1 receptor axis in multiple myelomaMENU, Eline; VAN VALCKENBORGH, Els; VAN CAMP, Ben et al.Archives of physiology and biochemistry. 2009, Vol 115, Num 2, pp 49-57, issn 1381-3455, 9 p.Conference Paper

Delayed in vivo disease progression is associated with high proportions of CD45⁺ myeloma cells in the 5T2MM murine modelASOSINGH, Kewal; WILLEMS, Angelo; VAN RIET, Ivan et al.Cancer research (Baltimore). 2003, Vol 63, Num 12, pp 3019-3020, issn 0008-5472, 2 p.Article

Chronic Administration of Valproic Acid Inhibits Activation of Mouse Hepatic Stellate Cells In Vitro and In VivoMANNAERTS, Inge; NUYTTEN, Nele R; ROGIERS, Vera et al.Hepatology (Baltimore, Md.). 2010, Vol 51, Num 2, pp 603-614, issn 0270-9139, 12 p.Article

The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myelomaSHIPMAN, Claire M; VANDERKERKEN, Karin; ROGERS, Michael J et al.British journal of haematology. 2000, Vol 111, Num 1, pp 283-286, issn 0007-1048Article

Homing of the myeloma cell cloneVANDERKERKEN, Karin; VAN CAMP, Ben; DE GREEF, Catherine et al.Acta oncologica (Stockholm). 2000, Vol 39, Num 7, pp 771-776, issn 0284-186XConference Paper

Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibitionJINSONG HU; NANA DANG; MENU, Eline et al.Blood. 2012, Vol 119, Num 3, pp 826-837, issn 0006-4971, 12 p.Article

Targeting the IGF-1R using picropodophyllin in the therapeutical 5T2MM mouse model of multiple myeloma : Beneficial effects on tumor growth, angiogenesis, bone disease and survivalMENUL, Eline; JERNBERG-WIKLUND, Helena; VAN CAMP, Ben et al.International journal of cancer. 2007, Vol 121, Num 8, pp 1857-1861, issn 0020-7136, 5 p.Article

The involvement of osteopontin and its receptors in multiple myeloma cell survival, migration and invasion in the murine 5T33MM modelCAERS, Jo; GÜNTHERT, Ursula; DE RAEVE, Hendrik et al.British journal of haematology. 2006, Vol 132, Num 4, pp 469-477, issn 0007-1048, 9 p.Article

Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progressionASOSINGH, Kewal; DE RAEVE, Hendrik; DE RIDDER, Mark et al.Haematologica (Roma). 2005, Vol 90, Num 6, pp 810-817, issn 0390-6078, 8 p.Article

Part of the multiple myeloma-associated microvessels is functionally connected to the systemic circulation: a study in the murine 5T33MM modelDE RAEVE, Hendrik R; ASOSINGH, Kewal; WISSE, Eddie et al.Virchows Archiv. 2004, Vol 445, Num 4, pp 389-395, issn 0945-6317, 7 p.Article

Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone diseaseCROUCHER, Peter I; SHIPMAN, Claire M; VAN CAMP, Ben et al.Cancer. 2003, Vol 97, Num 3, pp 818-824, issn 0008-543X, 7 p., SUPConference Paper

Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like featuresKAREEM AZAB, Abdel; JINSONG HU; ROCCARO, Aldo M et al.Blood. 2012, Vol 119, Num 24, pp 5782-5794, issn 0006-4971, 13 p.Article

Apomine™, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivoEDWARDS, Claire M; MUELLER, Gabrielle; VANDERKERKEN, Karin et al.International journal of cancer. 2007, Vol 120, Num 8, pp 1657-1663, issn 0020-7136, 7 p.Article

Angiogenic switch during 5T2MM murine myeloma tumorigenesis: role of CD45 heterogeneityASOSINGH, Kewal; DE RAEVE, Hendrik; MENU, Eline et al.Blood. 2004, Vol 103, Num 8, pp 3131-3137, issn 0006-4971, 7 p.Article

Multifunctional role of matrix metalloproteinases in multiple myeloma: A study in the 5T2MM mouse modelVAN VALCKENBORGH, Els; CROUCHER, Peter I; VAN RIET, Ivan et al.The American journal of pathology. 2004, Vol 165, Num 3, pp 869-878, issn 0002-9440, 10 p.Article

Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: Evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survivalCROUCHER, Peter I; DE RAEVE, Hendrik; PERRY, Mark J et al.Journal of bone and mineral research (Print). 2003, Vol 18, Num 3, pp 482-492, issn 0884-0431, 11 p.Article

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myelomaCROUCHER, Peter I; SHIPMAN, Claire M; DUNSTAN, Colin R et al.Blood. 2001, Vol 98, Num 13, pp 3534-3540, issn 0006-4971Article

Stimulation of invariant natural killer T cells by α-Galactosylceramide activates the JAK-STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma modelNUR, Haneen; RAO, Luigia; MENU, Eline et al.British journal of haematology. 2014, Vol 167, Num 5, pp 651-663, issn 0007-1048, 13 p.Article